BlueDil International’s offering

Timing is key.
BlueDil offers a flexible, customized approach to support you at every stage, from pre-launch to post-launch strategies, for your orphan therapy. Discover how we can support your product’s lifecycle for success in Europe!




Partnering and supporting across all product lifecycle

BlueDil International (BDI) Fields of Expertise

Strategic Opportunity Evaluation

offering orphan drug opportunity

Strategic Opportunity Evaluation

Harness BDI’s deep understanding of rare diseases complex market through in-depth qualitative research, Key Opinion Leaders interviews and Advisory Boards. Our scientific expertise enables us to uncover strategic opportunities and deliver actionable insights.

Clinical studies: Accelerated Patient Recruitment and Early Access Programs (EAPs)

accelerated patient recruitment

Clinical studies: Accelerated Patient Recruitment and Early Access Programs (EAPs)

Patient recruitment in clinical trials for orphan therapies might be challenging due to diseases low prevalence. BlueDil Int’l can support you in finding patients to enroll in clinical trials by establishing and nurturing the relationship with reference centers. Moreover, being time to access even more important for patients affected by a rare and often severe disease, BDI provides turnkey solutions to develop Early Access Programs.

Medical affairs

medical affairs

Medical affairs

BDI provides comprehensive support in Medical Affairs, including
mapping reference centers, building relationships with clinicians, and executing medical-scientific activities such as advisory boards, symposia, and educational initiatives.

Legal and Regulatory Affairs

orphan drug designation

Legal and Regulatory Affairs

BDI operates with the utmost respect for the current legal and regulatory frameworks at country and regional level, providing experienced professionals to guide you competently and transparently through the complexities of the various national health ecosystems.

Market Access, Price & Reimbursement

rare therapies market access

Market Access, Price & Reimbursement

Leverage BDI’s expertise to navigate the orphan drugs market. We craft tailored market access strategies that address the unique European, national, and regional requirements, ensuring optimal and compliant market entry.

Field Operations: Key Account Management (KAM) & Medical Scientific Liaison (MSL)

field operation

Field Operations: Key Account Management (KAM) & Medical Scientific Liaison (MSL)

At BDI, we deploy top-tier professionals such as MSLs and KAMs to drive medical, scientific, and commercial activities aligned with your product lifecycle, ensuring effective execution and impactful results.

Forecasting and Commercial Strategies

orphan drug forecasting

Forecasting and Commercial Strategies

BDI fine-tunes your commercial strategy by analyzing field insights and disease-specific factors. Our strategic forecasting and planning services help you navigate market dynamics and optimize your approach for maximum outcome.

Supply Chain: Logistics and Distribution

supply chain

Supply Chain: Logistics and Distribution

BDI supports an efficient and reliable supply chain set-up, fully compliant with EU and national regulations.

Affiliate Setup and Optimization: Human Resources, Recruitment, and Management

affiliate setup

Affiliate Setup and Optimization: Human Resources, Recruitment, and Management

BDI crafts personalized strategies for affiliate setup, operating as a Virtual Affiliate until you’re ready to establish your own offices. We provide comprehensive support throughout the entire process, from human resources and recruitment to management, ensuring a smooth transition and successful establishment.